76 episodes

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.

BioTech Nation ... with Dr. Moira Gunn Moira Gunn

    • Science
    • 4.1 • 28 Ratings

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.

    Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

    Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

    This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations and risks. Dr. Ang emphasizes the potential of their treatment to revolutionize AML therapy and improve patient outcomes.

    • 15 min
    Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics

    Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics

    In this week's episode of BioTech Nation, Dr. David Bearss, President and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses and its potential in treating chronic diseases like myelodysplastic syndrome and Alzheimer's. Dr. Bearss shares insights into Halia's groundbreaking approach and his relentless pursuit of medical breakthroughs.

    • 28 min
    Food as Medicine, A Personalized Prescription... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

    Food as Medicine, A Personalized Prescription... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

    Tech Nation Health, Chief Correspondent Dr. Daniel Kraft discusses the concept of "food as medicine." Dr. Kraft emphasizes the evolving understanding of nutrition and its profound impact on health, advocating for a shift towards personalized nutrition using cutting-edge technologies. From continuous glucose monitors to AI-powered apps and sensor toilets, we explore how these innovations enable individuals to measure and optimize their dietary choices. 

    • 10 min
    Repairing Minds, Naturally??? Mark Litton, President & CEO, Athira Pharma

    Repairing Minds, Naturally??? Mark Litton, President & CEO, Athira Pharma

    Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma.

    • 22 min
    Combatting Blood Clots!!! Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics

    Combatting Blood Clots!!! Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics

    This week, Dr. Daniel Bloomfield from Anthos Therapeutics discusses the prevalence and dangers of blood clots, particularly in patients with cancer. Dr. Bloomfield explains the difference between normal and abnormal blood clotting, the risks associated with blood clots in arteries and veins, and the challenges in balancing clot prevention with the risk of bleeding. 

    • 14 min
    Heartburn, GERD, Cancer??? Dr. Lishan Aklog, CEO of Lucid Diagnostics

    Heartburn, GERD, Cancer??? Dr. Lishan Aklog, CEO of Lucid Diagnostics

    Dr. Lishan Aklog from Lucid Diagnostics tells us about the path from GERD to, unfortunately, esophageal cancer, and about Lucid’s two-minute diagnostic test which can detect precancerous cells. 

    • 22 min

Customer Reviews

4.1 out of 5
28 Ratings

28 Ratings

Magical_smoke ,

It's great to listen to at work

Discussion of biotechnology future projects along with some current biotech.

MReza100 ,

I can't say how great it is.

This podcast always motivates me to study hard,and it gives me very good feeling about biotech,thank you so much for this incredible podcast

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson
Science Vs
Spotify Studios

You Might Also Like

The Readout Loud
STAT
Business Of Biotech
Matt Pillar
Living on Earth
World Media Foundation
Raising Health
Andreessen Horowitz
Diane Rehm: On My Mind
WAMU 88.5
WIRED Science
WIRED